Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted 02 July, 2010 and appeared in  ObesityType 2 DiabetesPreventionPhysical ActivityIssue 528

ADA: Exercise Alone Reduces Diabetes Risk in Obese Boys

Obese boys who engaged in regular aerobic or resistance exercise -- without dietary changes -- had significant improvements over 3 months in their total body fat, visceral adipose tissue concentrations, and insulin sensitivity than their more sluggish counterparts, according to the results of a randomized study....

Advertisement

The results were independent of the type of exercise assigned, and suggest that a moderate increase in activity (180 minutes per week) can help prevent Type 2 diabetes in this high-risk population, said SoJung Lee, PhD, assistant professor of pediatrics at the Children's Hospital of Pittsburgh in Pennsylvania. 

The hypothesis was that "aerobic training would be more beneficial than resistance training for adipose tissue reduction and insulin resistance reduction, but I guess our hypothesis was wrong. We have pilot data [supporting the fact] that during resistance training, the energy expenditure in boys is similar to aerobic training."

To determine the effects of regular exercise without diet on total and abdominal fat and insulin resistance, and to see whether different forms of exercise would produce different outcomes, the investigators designed a randomized study of 26 obese boys, ranging in age from 12 to 18 years. The subjects all had a body mass index in the 95th percentile or higher (mean, 34.9 + 4.6 kg/m2).

The boys were randomly assigned to 1 of 3 groups for the 3-month study: aerobic exercise for 180 minutes/week (n = 9), resistance exercise for 180 minutes/week (n = 11), or no exercise (n = 6; control group). Although boys in the control group were asked to eat a healthy diet, none of the participants were on calorie-restricted diets.

The primary study end points were change from baseline in total and regional body composition measured by whole-body magnetic resonance imaging, and insulin sensitivity measured by a 3-hour hyperinsulinemic-euglycemic clamp.

After 3 months, there were no significant changes in mean body weight in either the aerobic group (–1.0 ± 2.12 kg) or the resistance group (0.3 ± 0.6 kg;> .10). In contrast, those in the control group, on average, gained more than 4 kg (4.4 ± 0.8 kg; < .05).

Exercisers had significant gains in cardiorespiratory fitness, compared with controls; the gain in the aerobic group was 37.2% and in the resistance group was 24.9% (< .05 for each, compared with control group).

Total body fat declined by 9.6% among the aerobic exercisers, and by 4.7% among resistance exercisers (< .05 for each vs controls). Similarly, visceral adipose tissue concentrations dropped by 12.6% and 13.3%, respectively (< .50). There were no significant differences in abdominal fat changes between the exercise groups (> .01).

The insulin sensitivity analysis also showed a benefit in each exercise group, with a 23.3% gain with aerobics and a 35.6% gain with resistance. There were no significant differences in insulin sensitivity between the exercise groups, however (> .10).

Across all 3 groups, change in abdominal fat correlated significantly with insulin sensitivity (r = –0.45; < .05).

Andrew W. Norris, MD, PhD, Assistant professor of pediatrics at the University of Iowa in Iowa City, stated that the study suggests that exercise interventions can work in an at-risk population such as this, particularly when children are given a choice. "These results are particularly nice to see in boys, since it seems they can become highly motivated to do exercise training. In particular, it looked like the boys were quite interested in weight training, which may be a nice modality to be able to treat them."

American Diabetes Association (ADA) 70th Scientific Sessions: Abstract 22-OR. Presented June 25, 2010.

 

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 02 July, 2010 and appeared in  ObesityType 2 DiabetesPreventionPhysical ActivityIssue 528

Past five issues: Diabetes Clinical Mastery Series Issue 85 | Issue 626 | Special Edition - Getting Patients on Track | Diabetes Clinical Mastery Series Issue 84 | Issue 625 |

 
Diabetes In Control Advertisers
 
 
Cast Your Vote
Now that once-weekly GLP-1 is available, which product are you recommending for your type 2 patients?

Navigate Diabetes In Control
Announcement:
Search Articles On Diabetes In Control